ESR1 and breast carcinoma: Interestingly, quantitative proteomic analysis by Zeng et al. showed that estrogen receptor alpha (ERα) expression was significantly inhibited in luminal breast cancer cells (MCF-7), where MCAM overexpression led to increased EMT.